M L And Sons
GANDHIBAG, Nagpur, Maharashtra
GST No. 27AAVFM6337R1Z4
TrustSEAL Verified
Call 0804763807450% Response Rate
SEND EMAIL

Pharma Medicines

100% Export Oriented Unit of a wide range of products which include forteo injection teriparatide, dutas t dutasteride and tamsulosin capsules, dutas tablets, molcovir 200 and molnupiravir capsules.

Forteo Injection Teriparatide

Forteo Injection Teriparatide
  • Forteo Injection Teriparatide
  • Forteo Injection Teriparatide
  • Forteo Injection Teriparatide
Get Best Quote
Approx. Price: Rs 23,640 / StripeGet Latest Price

Product Details:

Minimum Order Quantity1 Stripe
Packaging TypeBox
Dosage FormInjection
Packaging Sizeinjection/pen
Dose/Strength600 mcg
BrandForteo
Manufactured ByLilly

Forteo 600mcg Injection is a synthetic form of a natural human hormone called parathyroid hormone (PTH). It works by activating cells that build up bone and increase bone strength, thereby minimizing the risk of fractures. used mainly for treating osteoporosis.
Request
Callback
Yes! I am Interested

Dutas T Dutasteride and Tamsulosin Capsules

Dutas T Dutasteride and Tamsulosin Capsules
  • Dutas T Dutasteride and Tamsulosin Capsules
  • Dutas T Dutasteride and Tamsulosin Capsules
  • Dutas T Dutasteride and Tamsulosin Capsules
Get Best Quote
Approx. Price: Rs 3,100 / BoxGet Latest Price

Product Details:

Minimum Order Quantity1 Box
Usage/ApplicationPersonal
Medicine TypeOral
Grade StandardPharmaceutical
Product TypeFinished Product
Packaging Size10 X (10 + 10)
Packaging Type10 X (10 + 10)
IngredientsDutasteride and Tamsulosin

This medication is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It works by reducing the size of the enlarged prostate. ... Dutasteride is not approved for prevention of prostate cancer.
Request
Callback


Additional Information:

  • Item Code: DUT123
  • Production Capacity: N/A
  • Delivery Time: 10 Days
Yes! I am Interested

Dutas Tablets

Dutas Tablets
  • Dutas Tablets
  • Dutas Tablets
  • Dutas Tablets
  • Dutas Tablets
Get Best Quote
Approx. Price: Rs 560 / StripeGet Latest Price

Product Details:

Minimum Order Quantity1 Stripe
Pack size30 Capsules
ManufacturerDr Reddys
Prescription/Non prescriptionPrescription
BrandDutas
Usage/ApplicationPersonal
Grade StandardMedicine
Medicine TypeDutasteride
Product TypeFinished Product
Packing Size10 x 15's
Packaging Size10 X 30 Capsules
FormTablet
Manufactured ByDr.Reddy's

Dutas 0.5mg Soft Gelatin Capsule is a 5-alpha reductase inhibitors. It blocks an enzyme which is necessary to change
to another hormone that causes the prostate to grow. As a result, it helps to shrink the prostate and relieve the symptoms like difficulty in passing urine.
Request
Callback


Additional Information:

  • Pay Mode Terms: T/T (Bank Transfer),paypal wire transfer
  • Port of Dispatch: mumbai
  • Delivery Time: 5-7 days
Yes! I am Interested

Molcovir 200

Molcovir 200
  • Molcovir 200
  • Molcovir 200
  • Molcovir 200
Get Best Quote
Approx. Price: Rs 300 / BottleGet Latest Price

Product Details:

Strength200 mg
Packaging Size4X10 Tablets
ManufacturerHetero Healthcare
Composition200 mg
TreatmentCovid
Prescription/Non prescriptionPrescription
FormTablet
BrandMolcovir
Also givesPCD Pharma

We “ML & Sons” are Partnership based firm, involved as the Wholesale Trader And Exporter of Diabetic Medicine, Pharmaceutical Vaccine, and much more.
Request
Callback
Yes! I am Interested

Molnupiravir Capsules

Molnupiravir Capsules
  • Molnupiravir Capsules
Get Best Quote
Approx. Price: Rs 300 / BottleGet Latest Price

Product Details:

Packaging Size40 Capsule
Strength200 Mg
CompositionMolnupiravir
FormTablet
BrandMovfor
ManufacturerHetetro

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
The drug was developed at Emory University by the university's drug innovation company, Drug Innovation Ventures at Emory (DRIVE). It was then acquired by Miami-based company Ridgeback Biotherapeutics, who later partnered with Merck & Co. to develop the drug further.
Safety controversyIn April 2020, a whistleblower complaint by former Head of US Biomedical Advanced Research and Development Authority (BARDA) Rick Bright revealed concerns over providing funding for the further development of molnupiravir due to similar drugs having mutagenic (DNA damaging) properties.[3] A previous company, Pharmasset, that had investigated the drug's active ingredient had abandoned it. These claims were denied by George Painter, CEO of DRIVE, noting that toxicity studies on molnupiravir had been carried out and data provided to regulators in the US and UK, who permitted safety studies in humans to move forward in the spring of 2020. Also at this time, DRIVE and Ridgeback Biotherapeutics stated they planned future safety studies in animals.
COVID-19In late July 2020 Merck, which had been partnering with Ridgeback Biotherapeutics on developing the drug, announced its intention to move molnupiravir to late stage trials beginning in September 2020. On October 19 2020, Merck began a one year Stage 2/3 trial focused on hospitalized patients.
Request
Callback
Yes! I am Interested
X

Explore More Products

View All Products




Reach Us
Akshay Agrawal (Partner)
M L And Sons
87b, G.M. MARKET, AGRASEN SQUARE, C.A. ROAD, , NAGPUR - 440002
GANDHIBAG, Nagpur - 440018, Maharashtra, India


Call Us


Send E-mail